<p>Overall survival rates base on pN and LNR classification according to the number of lymph nodes examined.</p
<p>MLND, mediastinal lymph node dissection; MLNS, mediastinal lymph node sampling; HR, hazard ratio;...
A for 0 vs. 1 vs. 2 vs. 3 vs. 4 vs. 5 vs. 6 vs. 7+; B for 0 vs. 1–2 vs. 3+; C for ratio of positive ...
<p>(A) Overall survival curves of the new predictor (<i>p</i><0.001). (B) Disease free survival curv...
<p>Overall survival according to LNR categories, stratified by the number of examined lymph nodes.</...
<p>(A) Overall survival curves of nLNs (<i>p</i><0.001). (B) Disease free survival curves of nLNs (<...
<p>Overall survival according to AJCC N stage, stratified by the number of examined lymph nodes.</p
<p>Cumulative survival rates in relation to lymph node metastasis, together with the p value from th...
<p>Cumulative survival of patients stratified by the number of lymph node metastases (pN).</p
<p>Overall survival and disease-free survival of patients in the primary NACT group by the number of...
<p>(<b>a</b>) Survival curves stratified by AJCC pN categories; (<b>b</b>) Survival curves stratifie...
<p>Overall survival in patients with different extents of cervical lymph node involvement.</p
<p>(A) A cancer-specific survival (CSS) curve for patients with lymph node counts of 1–16 and over 1...
<p>A) patient survival among each combination of status-based lymph node groups, B) patient survival...
<p>Overall survival in N1a colon cancer patients, divided by lymph node sampling status.</p
<p>(A) A cancer-specific survival (CSS) curve for patients with lymph node count of 1–5, 6–10, 11–16...
<p>MLND, mediastinal lymph node dissection; MLNS, mediastinal lymph node sampling; HR, hazard ratio;...
A for 0 vs. 1 vs. 2 vs. 3 vs. 4 vs. 5 vs. 6 vs. 7+; B for 0 vs. 1–2 vs. 3+; C for ratio of positive ...
<p>(A) Overall survival curves of the new predictor (<i>p</i><0.001). (B) Disease free survival curv...
<p>Overall survival according to LNR categories, stratified by the number of examined lymph nodes.</...
<p>(A) Overall survival curves of nLNs (<i>p</i><0.001). (B) Disease free survival curves of nLNs (<...
<p>Overall survival according to AJCC N stage, stratified by the number of examined lymph nodes.</p
<p>Cumulative survival rates in relation to lymph node metastasis, together with the p value from th...
<p>Cumulative survival of patients stratified by the number of lymph node metastases (pN).</p
<p>Overall survival and disease-free survival of patients in the primary NACT group by the number of...
<p>(<b>a</b>) Survival curves stratified by AJCC pN categories; (<b>b</b>) Survival curves stratifie...
<p>Overall survival in patients with different extents of cervical lymph node involvement.</p
<p>(A) A cancer-specific survival (CSS) curve for patients with lymph node counts of 1–16 and over 1...
<p>A) patient survival among each combination of status-based lymph node groups, B) patient survival...
<p>Overall survival in N1a colon cancer patients, divided by lymph node sampling status.</p
<p>(A) A cancer-specific survival (CSS) curve for patients with lymph node count of 1–5, 6–10, 11–16...
<p>MLND, mediastinal lymph node dissection; MLNS, mediastinal lymph node sampling; HR, hazard ratio;...
A for 0 vs. 1 vs. 2 vs. 3 vs. 4 vs. 5 vs. 6 vs. 7+; B for 0 vs. 1–2 vs. 3+; C for ratio of positive ...
<p>(A) Overall survival curves of the new predictor (<i>p</i><0.001). (B) Disease free survival curv...
DOI
Add to ORKG